Filing Details
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 12, 2026.
The Healthcare company reported Q0 revenue of .
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 12, 2026.

At publication ·
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) · 10q filed
At a glance
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on November 12, 2026.
The Healthcare company reported Q0 revenue of .
Acurx Pharmaceuticals, Inc.'s stock currently trades at $0.98 with a market capitalization of $2.4M.
The 10-Q provides Acurx Pharmaceuticals, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Acurx Pharmaceuticals, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ACXP Stock Page
Browse all filings on our ACXP SEC filings page.
Public companies like Acurx Pharmaceuticals, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Keep reading
analyst ·
earnings ·
earnings ·
earnings ·
Current market data
NASDAQ · ACXP
$1.04
Up: +$0.01 · +0.97%
Live quote updated